Limula was created with the mission of making cell therapies accessible to everyone in need, at a reasonable cost, wherever they are. To achieve this goal, the startup based at StartLab has developed an automated solution that allows for a future where these revolutionary therapies will be produced in a decentralised way, directly in the hospital. The team was happy to announce this week the launch of its pilot phase at the Institut Paoli-Calmettes in Marseille. The early access program aims to collect feedback from early adopters about the technology.
